December 20, 2022
Webinar
New Jersey Intellectual Property Law Association (NJIPLA)
Finnegan partner David Weingarten will join a panel discussion on the patentability of chemical and pharmaceutical inventions at the New Jersey Intellectual Property Law Association’s webinar. Discussion content will also cover novelty, obviousness, sufficiency of disclosure, as well as differences between the U.S. and Europe. For more information, or to register, please see NJIPLA’s website.
European IP Blog
The Decision in G 1/25: A More Relaxed Approach to Description Amendments in Europe?
3 September 2026
At the PTAB Blog
Squires Issues Precedential Decision Clarifying Obviousness-Type Double Patenting Rejections
August 17, 2026
European IP Blog
UPC Action Permissibly Lodged Prior to the Grant of a European Patent
12 August 2026
Webinar
July 24, 2026
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.